A ma­jor­i­ty of phar­ma and biotech com­pa­nies pro­hib­it Chat­G­PT use, sur­vey finds

Most phar­ma and biotech com­pa­nies ban or re­strict the use of Chat­G­PT by their em­ploy­ees, ac­cord­ing to a re­cent sur­vey. Half of phar­ma and biotech …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.